Fisher & Paykel Healthcare Co. Limited (ASX:FPH – Get Free Report) insider Graham McLean bought 1,000 shares of the firm’s stock in a transaction on Monday, February 17th. The shares were purchased at an average price of A$32.30 ($20.57) per share, for a total transaction of A$32,300.00 ($20,573.25).
Fisher & Paykel Healthcare Stock Performance
The company has a market capitalization of $20.55 billion, a P/E ratio of 157.79, a P/E/G ratio of 4.47 and a beta of 0.42. The company has a current ratio of 1.83, a quick ratio of 0.79 and a debt-to-equity ratio of 10.75.
Fisher & Paykel Healthcare Increases Dividend
The business also recently disclosed a Interim dividend, which was paid on Tuesday, December 17th. Shareholders of record on Tuesday, December 17th were issued a dividend of $0.167 per share. This is a positive change from Fisher & Paykel Healthcare’s previous Interim dividend of $0.17. This represents a yield of 0.49%. The ex-dividend date was Wednesday, December 4th. Fisher & Paykel Healthcare’s dividend payout ratio (DPR) is 180.95%.
About Fisher & Paykel Healthcare
Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide. It also provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital.
Featured Stories
- Five stocks we like better than Fisher & Paykel Healthcare
- Buy P&G Now, Before It Sets A New All-Time High
- MarketBeat Week in Review – 02/17 – 02/21
- How to Calculate Inflation Rate
- SolarEdge: A Surprising Bright Spot in a Troubled Solar Industry?
- How to Buy Cheap Stocks Step by Step
- 3 Stocks Poised to Thrive as NVIDIA Dominates the AI Boom
Receive News & Ratings for Fisher & Paykel Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fisher & Paykel Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.